Discover the Largest Pharmaceutical Exhibition in Asia Returning to Shanghai in June 2026

CPHI & PMEC China 2026: The Premier Pharma Event in Shanghai

After a successful run in previous years, the largest pharmaceutical exhibition in Asia is making its highly anticipated return to Shanghai. Scheduled for June 16 to 18, 2026, at the Shanghai New International Expo Centre (SNIEC), CPHI & PMEC China is set to unite industry leaders from across the globe.

With an expected attendance of over 110,000 participants and more than 3,600 exhibitors, this event is unmatched in its scale and significance. As the leading destination for sourcing pharmaceutical ingredients and manufacturing solutions, CPHI & PMEC China offers unparalleled opportunities for networking, supply chain management, and fostering innovation within the pharmaceutical sector.

The rapid growth of this event correlates with China's emergence as a global powerhouse for pharmaceutical operations, showcasing a wide array of products and solutions crucial for advancing modern medicine. This includes active pharmaceutical ingredients (APIs), natural extracts, biotech products, advanced machinery, and even Traditional Chinese Medicine (TCM).

Orhan Caglayan, Executive Vice President of Pharma Portfolio at Informa Markets, remarks, "The expansion of CPHI & PMEC China not only highlights China's innovative capabilities but also cements its role as a leading destination for partnership and supply chain optimization. The 2026 edition showcases the industry's resilience and forward-thinking approach."

This year’s event will introduce expanded sections, featuring pavilions dedicated to Traditional Chinese Medicine and cutting-edge API showcases. Attendees will be treated to specialized areas highlighting medical aesthetic packaging and next-gen lab technologies, enhancing the already comprehensive offerings of the exhibition.

Participants will have the chance to engage with Asia's largest concentration of pharmaceutical machinery manufacturers and explore pioneering production technologies. CPHI & PMEC China will also host live demonstrations, technical seminars, and various networking programs, including the Hosted Buyer Matchmaking Program, which facilitates direct connections between international buyers and top suppliers.

The conference agenda is robust with over 100 sessions planned, led by more than 700 industry experts and officials. These gatherings will arm attendees with invaluable market insights and technical knowledge crucial for navigating the complexities of rapid pharmaceutical innovation. Topics will cover everything from investigational drugs to the latest developments in biotech and machinery.

For those seeking to stay ahead of trends in pharmaceutical innovation and production, CPHI & PMEC China 2026 provides a definitive platform. It is an opportunity to source from China’s leading manufacturers, discover TCM ingredients, evaluate pharmaceutical machinery, and network with key stakeholders in the industry.

To secure your place at this premier event, visit CPHI's official website for more information and registration. Don’t miss out on being part of this integral gathering that shapes the future of the pharmaceutical landscape.

In summary, CPHI & PMEC China 2026 promises to be an unmissable opportunity for all parties involved in the pharmaceutical sector, illustrating the continuous growth and innovation within this vital industry.